Medicover

The number of shares and votes in Medicover AB (publ) (“Medicover” or the “company”) has changed as a result of conversions of in total 33,300 class A shares into B shares carried out in April following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association.

Today, the last trading day of the month, there are in total 153,535,195 shares in Medicover, of which 76,631,101 are class A shares, together carrying 76,631,101 votes, 73,021,272 are class B shares, together carrying 7,302,127.2 votes and 3,882,822 are class C shares, together carrying 388,282.2 votes. The total number of votes in Medicover is 84,321,510.4.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is required to publish the information contained in this press release pursuant to the Swedish Financial Instruments Trading Act. The information was provided for publication by the abovementioned contact person at 10.00 CEST on 30 April 2024.

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2023, Medicover had revenue of €1,746 million and more than 45,000 employees. For more information, go to www.medicover.com